General MedicationsINJECTIONGeneric

ANTIZOL

FOMEPIZOLE

Standard Dose

1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview ANTIZOL is listed in Drugs@FDA under application 020696 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FOMEPIZOLE Form and strength INJECTABLE;INJECTION - 1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PAR PHARM INC Submission history Latest submission status date: 2020-12-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview ANTIZOL is listed in Drugs@FDA under application 020696 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FOMEPIZOLE Form and strength INJECTABLE;INJECTION - 1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PAR PHARM INC Submission history Latest submission status date: 2020-12-23 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.